Your English writing platform
Discover LudwigSimilar(60)
Compounds such as cetuximab, gefitinib, and erlotinib could prove valid for targeting tumours expressing EGFR in patients selected according to this marker and may represent a novel therapeutic strategy in patients with CUP (Sequist et al, 2007).
It could prove brittle.
It could prove crucial.
It could prove a fateful advantage.
It could prove a daunting challenge.
Who knew it could prove so controversial?
Yet it could prove short-lived.
But it could prove a risky strategy.
It could prove useful reading.
A Jean presidency could not only prove unwise, it could prove disastrous.
If so, it could prove comforting.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com